Antifungal therapy – Page 20

In vitro characterization of Trichophyton rubrum biofilm by combined anti-biofilm enzymes

mycolabadmin

Athlete’s foot and nail fungal infections caused by Trichophyton rubrum are difficult to treat because the fungus forms protective biofilms that resist antifungal medications. This research shows that enzymes like cellulase, protease, and amylase can break down these biofilm barriers when used alone or in combination. The combination approach was most effective, suggesting that enzyme-based treatments could become useful additions to current fungal infection therapies.

The tell-tale hearts: Donor-derived invasive fungal infections among orthotopic heart transplant recipients

mycolabadmin

This case report describes two rare instances where fungal infections were transmitted from organ donors to heart transplant recipients. One involved a Candida infection and the other involved Aspergillus fungus, both causing serious bloodstream and heart infections. The patients required extensive antifungal medications and multiple surgeries to survive their infections, though they experienced significant complications. These cases highlight the importance of careful screening of organ donors for undetected infections.

Efficacy and safety of isavuconazole for invasive fungal infections: A systematic review and meta-analysis of randomized controlled trials

mycolabadmin

Isavuconazole is an antifungal medication used to treat serious fungal infections that can occur in people with weakened immune systems. This research review looked at three clinical trials comparing isavuconazole to other antifungal drugs and found it works just as well while being easier on the liver. Notably, isavuconazole caused fewer drug-related side effects and liver problems compared to voriconazole, another common antifungal drug.

A case of corneal infection with Clonostachys rosea

mycolabadmin

A 53-year-old patient developed a corneal infection caused by a fungus called Clonostachys rosea, likely from an eye injury. This is the first reported case of this particular fungus infecting the cornea. The infection was successfully treated with antifungal eye drops and oral medications, with the ulcer healing into a scar within one month.

Cryptococcal endophthalmitis in a patient with malignancy: A case report and literature review

mycolabadmin

A 50-year-old woman with advanced lung cancer developed a rare fungal eye infection caused by Cryptococcus neoformans, resulting in blurred vision. Doctors diagnosed this through eye surgery and fluid analysis, then treated her with strong antifungal medications both injected into the eye and given systemically. After 10 months of treatment, her vision significantly improved, showing that early detection and aggressive antifungal therapy are critical for preventing blindness from this rare infection.

Diagnostic Approaches to Invasive Candidiasis: Challenges and New Perspectives

mycolabadmin

Invasive candidiasis is a dangerous fungal infection affecting critically ill hospital patients. Current testing methods like blood cultures are slow and unreliable, so doctors are developing faster tests using DNA detection and biomarkers. A combination of new diagnostic tools and prompt treatment with antifungal medications is essential to improve survival rates and reduce complications from this serious infection.

Invasive Cutaneous Mucormycosis in a Patient With Chronic Lymphocytic Leukemia on Obinutuzumab, Idelalisib, and Bruton Tyrosine Kinase Degrader: A Case Report

mycolabadmin

A 74-year-old man with leukemia developed a serious fungal infection (mucormycosis) on his ankle while taking cancer-fighting drugs. The infection was diagnosed through tissue biopsy examination rather than standard culture tests. Treatment required both powerful antifungal medications and surgical removal of the infected leg below the knee. The patient recovered successfully after this aggressive treatment approach.

Antifungal potential of copper oxide nanoparticles against Microsporum canis isolates in canine and feline dermatophytosis

mycolabadmin

Researchers tested tiny copper oxide particles created using plant extracts against a fungus that causes ringworm in dogs and cats. These nanoparticles successfully killed the fungus in laboratory tests, with effectiveness at concentrations ranging from 500-2,000 parts per million. While slightly less effective than current medications, the nanoparticles showed promise as an alternative treatment, especially important as the fungus becomes resistant to traditional drugs.

Cryptococcus albidus (Naganishia albida) meningitis in a young patient with T-cell acute lymphoblastic leukaemia

mycolabadmin

A 16-year-old boy with blood cancer developed meningitis caused by a rare fungus called Cryptococcus albidus. Doctors initially thought he had a viral infection, but laboratory tests identified the fungus. He was treated with antifungal medications and improved significantly. This case shows how important it is to identify the correct cause of infection quickly, especially in patients with weakened immune systems.

Cutaneous Purpureocillium lilacinum and Fusarium coinfection in a heart transplant recipient

mycolabadmin

A heart transplant patient developed multiple nodular skin lesions caused by two rare types of mold fungi growing together. Doctors diagnosed the infection through skin biopsy and identified the fungi using laboratory techniques. The patient was successfully treated with the antifungal medication voriconazole for six months and made a full recovery without relapse.

Research Topic: Antifungal therapy